Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

GDOC vs VGHCX overlap: 50% of top holdings shared

Bottom line

How much do GDOC and VGHCX overlap?

50% of their top holdings overlap by weight. 11 securities appear in both funds' top 25, making up 52.2% of GDOC's assets and 37.6% of VGHCX's. They share a meaningful core but differ in the rest of the portfolio.

VGHCX holds far more positions (97 vs 42), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

GDOCVGHCX
Weight overlap (top 25)50%
Shared holdings11
Weight in shared holdings52.2%37.6%
Total positions4297
Expense ratio0.75%0.33%
Holdings as ofMay 31, 2026Jul 31, 2026

Source: SEC Form N-PORT (periods May 31, 2026 / Jul 31, 2026)

Holdings GDOC and VGHCX have in common

Holding% of GDOC% of VGHCXOverlap
Eli Lilly & Company LLY13.28%8.61%8.61%
Johnson & Johnson JNJ8.07%4.83%4.83%
Merck & Company Inc MRK5.94%5.44%5.44%
Astrazeneca Plc AZN4.84%4.59%4.59%
Intuitive Surgical Inc ISRG3.90%2.52%2.52%
Boston Scientific Corp BSX3.78%1.53%1.53%
Edwards Lifesciences Corp EW2.98%2.56%2.56%
Dexcom Inc DXCM2.79%1.18%1.18%
Agilent Technologies Inc A2.77%1.49%1.49%
Cencora Inc COR2.34%2.47%2.34%
Vertex Pharmaceuticals Inc VRTX1.48%2.36%1.48%

Source: SEC Form N-PORT (periods May 31, 2026 / Jul 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in GDOC

  1. Guardant Health Inc — 5.34%
  2. Thermo Fisher Scientific Inc — 4.52%
  3. Argenx Se — 4.07%
  4. Hoya Corp — 3.53%
  5. Lonza Group Ag — 2.80%
  6. Roivant Sciences Ltd — 2.39%
  7. Apogee Therapeutics Inc — 1.97%
  8. Royalty Pharma Plc — 1.77%
  9. Penumbra Inc — 1.61%
  10. Mettler-toledo International Inc — 1.59%
  11. Goldman Sachs Trust — 1.43%
  12. Cytokinetics Inc — 1.40%
  13. Ionis Pharmaceuticals Inc — 1.37%
  14. Xenon Pharmaceuticals Inc — 1.35%

Only in VGHCX

  1. UnitedHealth Group Inc — 4.05%
  2. Gsk Plc — 3.00%
  3. CVS Health Corp — 2.52%
  4. AbbVie Inc — 2.30%
  5. Danaher Corp — 2.18%
  6. Regeneron Pharmaceuticals Inc — 2.14%
  7. Novartis AG — 1.91%
  8. Elevance Health Inc — 1.83%
  9. Argenx SE — 1.68%
  10. HCA Healthcare Inc — 1.68%
  11. Ucb Sa — 1.67%
  12. Biogen Inc — 1.46%
  13. Galderma Group AG — 1.37%
  14. Roche Holding AG — 1.18%

Asset mix

Asset typeGDOCVGHCX
Stocks98.5%97.6%
Repurchase agreements—2.2%
Cash & short-term funds1.4%0.1%

Source: SEC Form N-PORT (periods May 31, 2026 / Jul 31, 2026)

Country mix

CountryGDOCVGHCX
US76.3%77.6%
GB6.6%7.6%
JP3.5%4.8%
CH3.9%4.5%
NL4.1%—
BE—3.4%
BM2.4%—
CA1.9%—

Source: SEC Form N-PORT (periods May 31, 2026 / Jul 31, 2026)

Check another pair

FAQ

How much do GDOC and VGHCX overlap?
About 50% by weight. 11 securities appear in both funds' top 25 holdings; they make up 52.2% of GDOC's assets and 37.6% of VGHCX's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do GDOC and VGHCX have in common?
The largest shared holdings are Eli Lilly & Company, Merck & Company Inc, Johnson & Johnson, Astrazeneca Plc, Edwards Lifesciences Corp.
Should I own both GDOC and VGHCX?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, GDOC or VGHCX?
VGHCX is broader, with 97 positions versus 42 for GDOC. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.